ArticleJournal of neuro-oncology2026

Novel cilengitide derivatives suppress migration and invasion of temozolomide-resistant glioblastoma cells via MAPK/Akt pathway inhibition.

Yeonsoo Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.